Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers.
Ficlatuzumab was developed by AVEO Pharmaceuticals.
The source of this article is
wikipedia, the free encyclopedia. The text of this article is licensed under the
GFDL.
